Obesity drugs
Zealand Pharma shares tumble as safety data hit drug hopes
Survodutide met late-stage trial goals, but gastrointestinal side effects and a 19% dropout rate raised doubts about its commercial potential
Pharmaceuticals news
Read verified news on BetaVoices covering Pharmaceuticals, with reporting, context, and related developments.
#Pharmaceuticals
Clear filters